HomeTURTLEMINT › Filing
🔔 Get instant alerts when TURTLEMINT files quarterly results on BSE Start free trial →

Press Release

Filed: 17 Jul 2026, 18:51 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - FY26 - Revenue from operations grew 57% to INR 1,098 crore; Service EBITDA up 70% to INR 142 crore - Q4 FY26 delivered first profitable quarter with PAT of INR 3 crore and 42% revenue growth - Platform Premium increased 31% to INR 3,868 crore; renewal revenue grew 51% to INR 224 crore - Adjusted EBITDA margin improved from -27% to -10%; corporate overheads reduced to 23% of revenue - Digital Partners expanded to over 6.5 lakh, supported by 46 insurers across 19,000+ PIN codes
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TURTLEMINT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TURTLEMINT to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Turtlemint Fintech Solutions Limited

Important. The summary above is generated automatically from Turtlemint Fintech Solutions Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.